Ilya A. Pokataev

Moscow, MOW, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Morphological features of immune-related cutaneous adverse events associated with anti-PD-1/PD-L1 cancer immunotherapy

Morphological features of immune-related cutaneous adverse events associated with anti-PD-1/PD-L1 cancer immunotherapy

Journal: Arkhiv patologii

Published: July 30, 2026

Prevalence and clinicopathological correlates of MSI/dMMR in colorectal cancer: a prospective multicenter registry study from Russia.

Prevalence and clinicopathological correlates of MSI/dMMR in colorectal cancer: a prospective multicenter registry study from Russia.

Journal: Frontiers in oncology

Published: May 17, 2026

Multicenter Prospective Phase II Study of Induction Therapy With Pembrolizumab, Cisplatin, and Fluorouracil in Patients With Locally Advanced Head and Neck Cancer.

Multicenter Prospective Phase II Study of Induction Therapy With Pembrolizumab, Cisplatin, and Fluorouracil in Patients With Locally Advanced Head and Neck Cancer.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: May 14, 2026

Maintenance avelumab in metastatic urothelial carcinoma: do tumour site and previous surgery matter?

Maintenance avelumab in metastatic urothelial carcinoma: do tumour site and previous surgery matter?

Journal: BJU international

Published: August 29, 2025

Maintenance Therapy With Avelumab for Patients With Metastatic Urothelial Carcinoma: A Real-World, Ambispective RAVE-Bladder Study.

Maintenance Therapy With Avelumab for Patients With Metastatic Urothelial Carcinoma: A Real-World, Ambispective RAVE-Bladder Study.

Journal: Cancer medicine

Published: October 10, 2024

Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma.

Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: May 30, 2024

Mutations in Mismatch Repair Genes and Microsatellite Instability Status in Pancreatic Cancer.

Mutations in Mismatch Repair Genes and Microsatellite Instability Status in Pancreatic Cancer.

Journal: Cancers

Published: March 25, 2024

Surgical treatment and prognostic factors in perihilar tumors

Surgical treatment and prognostic factors in perihilar tumors

Journal: Khirurgiia

Published: February 12, 2024

Utility of public knowledge bases for the interpretation of comprehensive tumor molecular profiling results.

Utility of public knowledge bases for the interpretation of comprehensive tumor molecular profiling results.

Journal: Clinical and experimental medicine

Published: November 11, 2022

TYMS 3'-UTR Polymorphism: A Novel Association with FOLFIRINOX-Induced Neurotoxicity in Pancreatic Cancer Patients.

TYMS 3'-UTR Polymorphism: A Novel Association with FOLFIRINOX-Induced Neurotoxicity in Pancreatic Cancer Patients.

Journal: Pharmaceutics

Published: November 10, 2021

Platinum-based chemotherapy for pancreatic cancer: impact of mutations in the homologous recombination repair and Fanconi anemia genes.

Platinum-based chemotherapy for pancreatic cancer: impact of mutations in the homologous recombination repair and Fanconi anemia genes.

Journal: Therapeutic advances in medical oncology

Published: August 27, 2021

Intestinal microbiome as a predictor of the anti-PD-1 therapy success: metagenomic data analysis

Intestinal microbiome as a predictor of the anti-PD-1 therapy success: metagenomic data analysis

Journal: Biomeditsinskaia khimiia

Published: December 29, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026